UTI Extends 7.6 Billion Won Loan to Subsidiary UTI VINA VINH PHUC for 7 Years, Raising Concerns Over Financial Burden
UTI decided to extend the maturity of an existing 7.63 billion won loan to its subsidiary UTI VINA VINH PHUC by 7 years until July 2033. This is an extension, not a new loan.
The loan is for facility funding with an annual interest rate of 4.6%. The amount is based on USD 5 million.
UTI VINA VINH PHUC has weak financials: total equity of 9.9 billion won and net loss of 18.5 billion won in 2025. The total loan balance to this subsidiary reaches 58.2 billion won, increasing UTI's financial burden.
The decision was made at a board meeting with one outside director and an auditor present. No new shares or dilution involved.
[AI Summary]UTI's extension of loans to a loss-making subsidiary heightens credit risk. Total loans outstanding equal 74% of market cap, potentially impacting financial soundness. Short-term stock impact is limited but poses long-term investment risk.